French Maritime Pine Bark Extract Inhibits Viral Replication and Prevents Development of Viral Myocarditis

Journal of Cardiac Failure

Volumn 13, Issue 9, 2007, Pages 785-791

  Matsumori, Akira ^a   Higuchi, Hirokazu ^a   Shimada, Miho ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

collagen; inflammation; myocarditis; viruses

Indexed keywords

PROCOLLAGEN; PYCNOGENOL; STEM CELL FACTOR; TRYPTASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG INHIBITION; ENCEPHALOMYOCARDITIS VIRUS; GENE EXPRESSION; HEART MUSCLE NECROSIS; INOCULATION; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; VIRUS MYOCARDITIS; VIRUS REPLICATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; ENCEPHALOMYOCARDITIS VIRUS; FLAVONOIDS; MALE; MAST CELLS; MICE; MICE, INBRED DBA; MYOCARDITIS; MYOCARDIUM; PLANT EXTRACTS; PROCOLLAGEN; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; VIRUS DISEASES;

EID: 34648818550     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.06.721     Document Type: Article

References (30)

1. Matsumori A. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy. Role of virus, cytokines, and nitric oxide. Jpn Circ J 61 (1997) 275-291
2. Matsumori A., Yamada T., Suzuki H., Matoba Y., and Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72 (1994) 561-566
3. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
4. Yamada T., Matsumori A., and Sasayama S. Therapeutic effect of anti-tumor necrosis factor-α antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 89 (1994) 846-851
5. Shioi T., Matsumori A., and Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 94 (1996) 2930-2937
6. Iwasaki A., Matsumori A., Yamada T., Shioi T., Wang W.-Z., Ono K., et al. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis. J Am Coll Cardiol 33 (1999) 1400-1407
7. Matsumori A., Nunokawa Y., and Sasayama S. Pimobendan inhibits the activation of transcription factor NF-κB: a mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase. Life Sci 67 (2000) 2513-2519
8. The EPOCH Study Group. Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure-the effects of pimobendan on chronic heart failure study (EPOCH study). Circ J 66 (2002) 149-157
9. Matsumori A., Nunokawa Y., Yamaki A., Yamamoto K., Hwang M.W., Miyamoto T., et al. Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-κB inhibitor. Eur J Heart Fail 6 (2004) 137-144
10. Patella V., Marino I., Arbustini E., Lampater-Schummert B., Verga L., Adt M., et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic and ischemic cardiomyopathy. Circulation 97 (1998) 971-978
11. Hara M., Ono K., Hwang M.W., Iwasaki A., Okada M., Nakatani K., et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 195 (2002) 375-381
12. Kitaura-Inenaga K., Hara M., Higuchi K., Yamamoto K., Yamaki A., Ono K., et al. Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure. Circ J 67 (2003) 881-884
13. Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 40 (2002) 158-168
14. Maritime Pine Extract. In United States Pharmacopeia (2005), United States Pharmacopeial Convention, Inc, Rockville, Md 2115-6
15. Packer L., Rimbach G., and Virgili F. Antioxidant activity and biologic properties of a procyanidin- rich extract from pine (Pinus maritime) bark, pycnogenol. Free Radic Biol Med 27 (1999) 704-724
16. Rohdewald P.J. Pycnogenol, french maritime pine bark extract. In Encyclopedia of Dietary Supplements (2005), Marcel Dekker, New York 545-53
17. Matsumori A., and Kawai C. An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice. Circulation 65 (1982) 1230-1235
18. Matsumori A., and Kawai C. An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation 66 (1982) 355-360
19. Matsumori A., Wang H., Abelmann W.H., and Crumpacker C.S. Treatment of viral myocarditis with ribavirin in an animal preparation. Circulation 71 (1985) 834-839
20. Hosseini S., Pishnamazi S., Sadrzadeh S.M., Farid F., Farid R., and Watson R.R. Pycnogenol® in the management of asthma. J Med Food 4 (2001) 201-209
21. Lau B.H., Riesen S.K., Truong K.P., Lau E.W., Rohdewald P., and Barreta R.A. Pycnogenol as an adjunct in the management of childhood asthma. J Asthma 41 (2004) 825-832
22. Kyriazi M., Yova D., Rallis M., and Lima A. Cancer chemopreventive effects of Pinus Maritima bark extract on ultraviolet radiation and ultraviolet radiation- 7, 12, dimethylbenz(a) anthracene induced skin carcinogenesis of hairless mice. Cancer Lett (2005) 1-8
23. Sime S., and Reeve V.E. Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by topical Pycnogenol. Photochem Photobiol 79 (2004) 193-198
24. Grimm T., Chovanova Z., Muchova J., Sumegova K., Liptava A., Durackova Z., et al. Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J Inflamm 3 (2006) 1
25. Virgili F., Kobuchi H., and Packer L. Procyanidins extracted from Pinus maritime (Pycnogenol): scavengers of free radical species and modulators of nitrogen monoxide metabolism in activated murine RAW 264.7 macrophages. Free Radic Biol Med 24 (1998) 1120-1129
26. Park Y.C., Rimbach G., Saliou C., Valacchi G., and Packer L. Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages. FEBS Lett 465 (2000) 93-97
27. Cho K.J., Yun C.H., Yoon D.Y., Cho Y.S., Rimbach G., Packer L., et al. Effect of bioflavonoids extracted from the bark of Pinus maritime on proinflammatory cytokine interleukin-1 production in lipopolysaccharide-stimulated RAW 264.7. Toxicol Appl Pharmacol 168 (2000) 64-71
28. Peng Q., Wei Z., and Lau B.H. Pycnogenol inhibits tumor necrosis factor-alpha-induced nuclear factor kappa B activation and adhesion molecule expression in human vascular endothelial cells. Cell Mol Life Sci 57 (2000) 834-841
29. Saliou C., Rimbach G., Moini H., McLaughlin L., Hosseini S., Lee J., et al. Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratiocytes are modulated by a French maritime pine bark extract. Free Radic Biol Med 30 (2001) 154-160
30. Grimm T., Schafer A., and Hogger P. Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (Pycnogenol). Free Rad Biol Med 36 (2004) 811-822